Skip to main content
Premium Trial:

Request an Annual Quote

AxCell and Compaq Form Database Partnership

Premium

P

RINCETON, NJ--AxCell Biosciences, a wholly owned subsidiary of Cytogen, has entered into a partnership with Compaq to develop a database software package that the companies said will help select promising drug targets from protein pathway data generated by AxCell. The program will be facilitated by Compaq’s Alpha, high-performance, 64-bit systems to deliver speed and scalability advantages.

Using high-throughput methods, with InforMax, AxCell said it is creating what it calls an Inter-Functional Proteomic Database to identify protein interactions and novel drug targets, which are also potentially useful in determining which compounds are likely to have the fewest side effects.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.